Who owns biote Corp. (BTMD)? Elite investor 13F holders
2 tracked elite investors reported holding biote Corp as of 2026-06-30, including Bandera Partners, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Bandera Partners | BIOTE CORP | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 3903761.00 USD | 2065482.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | BIOTE CORP | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 434689.00 USD | 229994.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.